Biocartis Group NV

Major Shareholding Notification • Jun 4, 2015

FORM TR-1 BE PART I
1) Status of the notification
	Final
2) Issuer
Identification number 0505-640-808	Name BIOCARTIS
3) Reason for the notification
	Holding of voting securities upon first admission to trading
4) Notification by
	A parent undertaking or a controlling person
5) Persons subject to the notification requirement
	Name (& legal form for legal persons)	Address (for legal persons)
	Debiopharm Diagnostics S.A.	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland
	Debiopharm Holding S.A.	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland
	Rolland-Yves Mauvernay	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland
	6) Persons that dispose of, voting rights (Only to be filled in if art. 7 of the Law applies)
	Name (& legal form for legal persons)	Address (for legal persons)
			٠

Click

Please continue entering the information in part II concerning the
persons referred to in points 5 and 6

7) Date on which the threshold is crossed

1

27.04.2015 (DD/MM/YYYY)

8) Threshold that is crossed (in %)

$10$

If the holding has fallen below the lowest threshold, you have the option of not entering any numbers under point 10

9) Denominator

39'144'013

Please enter the denominator before filling in the data

10) Notified details

A) Voting rights	Previous notification		After the transaction
	# of voting rights		# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Rolland-Yves Mauvernay				0.00%
Debiopharm Holding SA		c		0.00%
Debiopharm Diagnostics SA		4'749'707		12.13%
subtotal		4'749'707		12.13%
	TOTAL	4'749'707		12.13%	0.00%

Start with "groups" of holders. Calculate subtotals and then finish with the Persons who are "alone".
The totals, subtotals and % will be updated once you have clicked on
ECALCULATE>

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments ×	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights
	TOTAL		(in relation to all expiration dates)	$\bf{0}$	$0.00\%$	45
			The totals will be updated once you have clicked on
	TOTAL (Voting rights & Equivalent financial instruments)			# of voting rights	% of voting rights
			CALCULATE	4'749'707	12.13%
	11) Chain of controlled undertakings through which the holding is effectively held, if applicable
Please describe, or join a diagram in attachment
	Debiopharm Diagnostics S.A. is controlled by Debiopharm Holding S.A., which is controlled by Rolland-Yves Mauvernay
12) In case of proxy voting for only one GM
Holder		will cease to hold / will hold again	$\Omega$		voting rights as of
13) Additional information
A) Convertible bonds and rights to subscribe to voting securities not yet issued
Holder	Type of financial instrument	Expiration date (DD/MM/YYYY)	Exercise/Conversion period or date	Number	# of voting rights that may be acquired if the instrument is exercised/converted
						$\bullet$
B) Shares without voting rights
Holder	Number
						٠
C) Remarks
This transparency declaration is made to the extent required by applicable law.
Done at	Lausanne, Switzerland				w
On	1.06.2015	(DD/MM/YYYY)
Name & capacity
	Debiopharm Diagnostics S.A. - Thierry Mauvernay, Delegate of the Board Debiopharm Group Debiopharm Holding S.A. - Thierry Mauvernay,		Signature		Malian	o
	Delegate of the Board Debiopharm Group Rolland-Yves Mauvernay, President Debiopharm		Signature Signature
	Group

$\tilde{\Sigma}$

FORM TR-1 BE PART II

Persons subject to the notification requirement

Name (& legal form for legal persons)	Address (registered office for legal persons)	Phone number	E-mail	Contact person for legal persons
Debiopharm Diagnostics S.A.	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland	0041 21 321 0111 info-	diagnostics@debiopharm.	Sophie Juon
Debiopharm Holding S.A.	123. Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland	0041 21 331 29	sophie.juon@debiopharm. com	Sophie Juon
Rolland-Yves Mauvernav	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland	0041 21 321 0191 rolland-	wes mauvernav@debionh	Sophie Juon

Mandatary

Name (& legal form for legal persons)	Address (registered office for legal persons)	Phone number	E-mail	Contact person for legal persons

Invoicing data

Name (& legal form for legal persons)	Address (registered office for legal persons)	Phone number	E-mail	Contact person for legal persons
Debiopharm Diagnostics S.A.	123, Chemin de la Glâne, 1677 Prez-vers-Siviriez, Switzerland (0041) 021 321	0111	linfo- Idiagnostics@debiopharm. com	Sophie Juon

The personal data provided via this form will be processed by the FSMA (Congresstraat/rue du Congrès 12-14, 1000 Brussels) in accordance with the Law of 8 December
1992 on the protection of privacy as regards the processin 2002 on the supervision of the financial sector and on financial services. Insofar as the processed data do not fall under the professional secrecy obligation of the
FSMA, the natural persons whose data are being processed